Skip to main content
Clinical Trials/NCT03181919
NCT03181919CompletedNot Applicable

Letrozole Step-up Protocol for Ovulation Induction in Infertile Women With PCOS

Benha University0 sites90 target enrollmentStarted: January 1, 2016Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
90
Primary Endpoint
Number of mature follicles

Study Overview

Brief Summary

the aim of the study is to compare between the step-up and conventional protocols in ovulation induction in infertile women with PCOS

Detailed Description

The current study was conducted in private outpatient clinic after being approved by the medical ethics committee. The study is a prospective randomized study consisting of 90 Egyptian patients diagnosed as having infertility with pcos .

Sample size determination:

Group sample sizes of 42 and 42 achieve 80% power based on study finding carried out by (Galal et al., 2014) to detect a difference of 0.7 between the null hypothesis that both group means are 2.2 and the alternative hypothesis that the mean of group 2 is 1.5 with known group standard deviations of 1.5 and 0.6 and with a significance level (alpha) of 0.05000 using a two-sided Mann-Whitney test assuming that the actual distribution is uniform.

Sample size was calculated by PASS 11 Computer program for sample size calculation.

Taking into consideration 10% drop out rate, the sample size will be increased to 45 patients in group I and another 45 patients in group II.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
20 Years to 35 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age: 20 -37 years old.
  • No conception for at least one year.
  • Diagnosis of PCO as established by Rotterdam criteria, endometriosis diagnosed by laparoscope or unexplained infertility.

Exclusion Criteria

  • Age < 20 and > 35 years old.
  • Uterine pathology e.g. fibroid or ovarian cyst.
  • Hyperprolactinemia, hypo or hyperthyroidism.
  • Impaired hepatic or renal function.
  • History of hypersensitivity to study drugs.

Arms & Interventions

Step Up group

Experimental

includes females taking Letrozole 5 mg tablets in a step-up protocol 5 mg in day one, 7.5 in day 2, 10 mg in days 3, 12.5 mg in day 4 and 15 in day 5 started in day 3 to day 7 of menstrual cycle.

Intervention: Letrozole (Drug)

Outcomes

Primary Outcomes

Number of mature follicles

Time Frame: 2 weeks

Secondary Outcomes

  • Pregnancy rate(one month)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Dr. Abou Bakr Mohamed El Nashaar

Professor of obstetric and gynecology Benha University

Benha University

Similar Trials

Letrozole Step-up Protocol for Ovulation... | Clinical Trial